home / stock / tgna / tgna news


TGNA News and Press, TEGNA Inc From 03/27/24

Stock Information

Company Name: TEGNA Inc
Stock Symbol: TGNA
Market: NYSE
Website: tegna.com

Menu

TGNA TGNA Quote TGNA Short TGNA News TGNA Articles TGNA Message Board
Get TGNA Alerts

News, Short Squeeze, Breakout and More Instantly...

TGNA - Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025

2023 Full-year results and business update Lead program TG4050 to deliver data in 2024. Advancements in other clinical programs and Research and Innovation (R&I) activity to deliver news flow and fuel growth in Transgene’s portfolio over the next 24 month...

TGNA - (TGNA) Technical Data

2024-03-26 03:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

TGNA - TEGNA to Host First Quarter 2024 Earnings Conference Call on Wednesday, May 8, 2024

TEGNA Inc. (NYSE: TGNA) will host a conference call to discuss its first quarter 2024 earnings results on Wednesday, May 8, 2024, at 10 a.m. (ET). The conference call will be webcast through the company’s website , and is open to investors, the financial community, the media and ot...

TGNA - TEGNA Inc (TGNA) announced stock dividend $0.11375 on Ex-Date March 07, 2024

2024-03-06 08:00:13 ET TEGNA Inc (TGNA) declaring a stock dividend of $0.11375 per share on Ex-Date : March 07, 2024. Shareholders on record as of March 08, 2024 are eligible for the dividend. The payment date is scheduled for April 01, 2024, and the declaration was officially made ...

TGNA - Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024

Poster presentation of new data from ongoing randomized Phase I trial targeting head and neck cancers Strasbourg, France, March 6, 2024, 7:30 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for t...

TGNA - How the (TGNA) price action is used to our Advantage

2024-03-05 12:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

TGNA - Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

Strasbourg (France), Tokyo (Japan) and Waltham, Mass (USA), March 5 th , 2024, 7:30 am CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation (NEC; TSE: 6701), a leader in IT, network and AI...

TGNA - Comscore and TEGNA Sign Multi-Year Agreement for Local Linear and Cross-Platform Audience Measurement

RESTON, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Comscore, Inc. (NASDAQ: SCOR) and TEGNA Inc. (NYSE: TGNA) today announced they have reached a comprehensive multi-year agreement on cross-platform audience measurement. Under the terms of the agreement, Comscore will extend its relationship with TEG...

TGNA - TEGNA Inc. Reports Fourth Quarter and Full-Year 2023 Results and Provides Business Update

Reports full-year 2023 results which met or exceeded all full-year 2023 guidance metrics Provides full-year 2024 outlook and free cash flow guidance for 2024-2025 Plans to return 40-60% of 2024-2025 free cash flow to shareholders through new capital allocation framework; r...

TGNA - Expected US Company Earnings on Thursday, February 29th, 2024

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...

Previous 10 Next 10